Article info
Coeliac disease
Original article
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study
- Correspondence to Professor Olivier Hermine, Department of Clinical Haematology, Necker Hospital, Paris 75015, France; ohermine{at}gmail.com
Citation
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study
Publication history
- Received August 10, 2018
- Revised October 15, 2018
- Accepted November 5, 2018
- First published November 17, 2018.
Online issue publication
July 05, 2019
Article Versions
- Previous version (17 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.